BiVictriX Therapeutics PLC
LSE:BVX
BiVictriX Therapeutics PLC
LSE:BVX
Price:
10
GBX
17.65%
Market Closed
Market Cap:
£8.3m
Income Statement
Earnings Waterfall
BiVictriX Therapeutics PLC
BiVictriX Therapeutics PLC
Income Statement
BiVictriX Therapeutics PLC
BiVictriX Therapeutics PLC
Currency: GBP
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||
| Operating Expenses |
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(2)
N/A
|
(3)
-76%
|
(3)
-13%
|
(3)
+5%
|
(3)
-7%
|
(3)
-7%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(1)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(4)
-44%
|
(3)
+18%
|
(3)
+5%
|
(3)
-7%
|
(3)
-7%
|
|
| Net Income | |||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
1
|
|
| Income from Continuing Operations |
(2)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
|
| Net Income (Common) |
(2)
N/A
|
(3)
-38%
|
(2)
+23%
|
(2)
+7%
|
(3)
-9%
|
(3)
-5%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.05
+17%
|
-0.04
+20%
|
-0.04
N/A
|
-0.04
N/A
|
-0.04
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
